MicroRNAs in ascending thoracic aortic aneurysms

Areti Moushi, Nir Pillar, Anna Keravnou, Marinos Soteriou, Noam Shomron, Marios A. Cariolou, Evy Bashiardes*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Thoracic Aortic Aneurysm (TAA) is characterized by the dilation of the aorta and is fatal if not diagnosed and treated appropriately. The underlying genetic mechanisms have not been completely delineated, so better knowledge of the physiopathology of TAAs is needed to improve detection and therapy. MicroRNAs (miRNAs) regulate gene expression post-transcriptionally and are known to be involved in cardiovascular diseases (CVDs). The current study aimed to identify miRNAs that can be used as possible biomarkers for the early diagnosis of patients with ascending TAAs (ATAAs). MiRNA expression was profiled by NanoString nCounter technology using 12 samples including tissue and pre- and post-surgical plasma from ATAA patients. Four miRNAs were selected and further validated by real time polymerase chain reaction (RT-PCR) in 22 plasma samples from which three miRNAs (hsa-miR140-5p, hsa-miR-191-5p and hsa-miR-214-3p) showed significant expression level differences between the two types of plasma samples. Further analyses of the corresponding predicted target genes by these miRNAs, revealed two genes (Myotubularin-related protein 4 (MTMR4) and Phosphatase 1 catalytic subunit β (PPP1CB)) whose expression was inversely correlated with the expression of their respective miRNAs. Overall, in this pilot study, we identified three miRNAs that might serve as potential biomarkers and therapeutic targets in ATAA.

Original languageEnglish
Article numberBSR20200218
JournalBioscience Reports
Issue number7
StatePublished - Jul 2020


FundersFunder number
Cyprus School of Molecular Medicine


    Dive into the research topics of 'MicroRNAs in ascending thoracic aortic aneurysms'. Together they form a unique fingerprint.

    Cite this